Health
Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting – News-Medical.Net
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance…
Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th…
Continue Reading
-
Noosa News20 hours agoTalented new artist on jazz scene
-
Noosa News20 hours agoUn-beer-lievable: SEQ costlier than Melbourne for housing, food, grog
-
Noosa News16 hours agoAustralian dairy farmers struggle to compete with cheap cheese imports
-
General21 hours agoUK govt to take emergency control of British Steel